1. Home
  2. YUMC vs MEDP Comparison

YUMC vs MEDP Comparison

Compare YUMC & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yum China Holdings Inc.

YUMC

Yum China Holdings Inc.

HOLD

Current Price

$49.41

Market Cap

16.7B

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$583.58

Market Cap

16.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YUMC
MEDP
Founded
1987
1992
Country
China
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.7B
16.1B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
YUMC
MEDP
Price
$49.41
$583.58
Analyst Decision
Hold
Analyst Count
0
12
Target Price
N/A
$479.64
AVG Volume (30 Days)
1.1M
208.8K
Earning Date
02-04-2026
02-09-2026
Dividend Yield
1.90%
N/A
EPS Growth
6.57
25.36
EPS
2.40
14.32
Revenue
$11,569,000,000.00
$2,358,373,000.00
Revenue This Year
$5.49
$21.43
Revenue Next Year
$5.76
$11.99
P/E Ratio
$21.09
$41.42
Revenue Growth
3.29
13.88
52 Week Low
$41.00
$250.05
52 Week High
$53.99
$628.92

Technical Indicators

Market Signals
Indicator
YUMC
MEDP
Relative Strength Index (RSI) 55.56 44.84
Support Level $48.53 $579.03
Resistance Level $51.38 $605.25
Average True Range (ATR) 1.03 18.58
MACD 0.17 -3.29
Stochastic Oscillator 56.25 5.49

Price Performance

Historical Comparison
YUMC
MEDP

About YUMC Yum China Holdings Inc.

With more than 18,000 units and USD 12 billion in systemwide sales in 2025, Yum China is the largest restaurant operator in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC and Pizza Hut, but the company's portfolio also includes other brands such as Little Sheep, Taco Bell, Huang Ji Huang, and Lavazza. Yum China is a trademark licensee of Yum Brands, paying 3% of KFC and Pizza Hut's systemwide sales to the company it separated from 2016.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: